MXPA05010532A - Diagnostico genetico prenatal no invasivo usando celulas transcervicales. - Google Patents

Diagnostico genetico prenatal no invasivo usando celulas transcervicales.

Info

Publication number
MXPA05010532A
MXPA05010532A MXPA05010532A MXPA05010532A MXPA05010532A MX PA05010532 A MXPA05010532 A MX PA05010532A MX PA05010532 A MXPA05010532 A MX PA05010532A MX PA05010532 A MXPA05010532 A MX PA05010532A MX PA05010532 A MXPA05010532 A MX PA05010532A
Authority
MX
Mexico
Prior art keywords
genetic diagnosis
invasive prenatal
prenatal genetic
transcervical cells
transcervical
Prior art date
Application number
MXPA05010532A
Other languages
English (en)
Inventor
Moshe D Fejgin
Original Assignee
Monaliza Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monaliza Medical Ltd filed Critical Monaliza Medical Ltd
Publication of MXPA05010532A publication Critical patent/MXPA05010532A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6879—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for sex determination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/38—Pediatrics
    • G01N2800/385—Congenital anomalies
    • G01N2800/387—Down syndrome; Trisomy 18; Trisomy 13

Abstract

Se proporciona un metodo libre de riesgos, no invasivo, de diagnostico prenatal. De acuerdo con el metodo de la presente invencion, especimenes transcervicales se someten a inmunotincion especifica a trofoblastos seguida de analisis PRINS y/o FISH para determinar el genero fetal y/o identificar anormalidades cromosomales en un feto.
MXPA05010532A 2003-04-03 2004-04-01 Diagnostico genetico prenatal no invasivo usando celulas transcervicales. MXPA05010532A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/405,698 US20040197832A1 (en) 2003-04-03 2003-04-03 Non-invasive prenatal genetic diagnosis using transcervical cells
PCT/IL2004/000304 WO2004087863A2 (en) 2003-04-03 2004-04-01 Non-invasive prenatal genetic diagnosis using transcervical cells

Publications (1)

Publication Number Publication Date
MXPA05010532A true MXPA05010532A (es) 2006-03-10

Family

ID=33097161

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05010532A MXPA05010532A (es) 2003-04-03 2004-04-01 Diagnostico genetico prenatal no invasivo usando celulas transcervicales.

Country Status (10)

Country Link
US (2) US20040197832A1 (es)
EP (1) EP1608781A4 (es)
JP (1) JP2006523100A (es)
KR (1) KR20050123139A (es)
CN (1) CN1798853A (es)
AU (1) AU2004225660A1 (es)
CA (1) CA2521032A1 (es)
MX (1) MXPA05010532A (es)
WO (1) WO2004087863A2 (es)
ZA (1) ZA200507910B (es)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU772603B2 (en) * 1998-10-29 2004-05-06 Cell Works Diagnostics, Inc. Multiple marker characterization of single cells
US6692952B1 (en) * 1999-11-10 2004-02-17 Massachusetts Institute Of Technology Cell analysis and sorting apparatus for manipulation of cells
US20060073509A1 (en) * 1999-11-18 2006-04-06 Michael Kilpatrick Method for detecting and quantitating multiple subcellular components
WO2004029221A2 (en) * 2002-09-27 2004-04-08 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
WO2004077021A2 (en) * 2003-02-27 2004-09-10 Lesko Stephen A Standardized evaluation of therapeutic efficacy based on cellular biomarkers
US20050181429A1 (en) * 2003-04-03 2005-08-18 Monaliza Medical Ltd. Non-invasive prenatal genetic diagnosis using transcervical cells
CA2529285A1 (en) * 2003-06-13 2004-12-29 The General Hospital Corporation Microfluidic systems for size based removal of red blood cells and platelets from blood
US20090136982A1 (en) 2005-01-18 2009-05-28 Biocept, Inc. Cell separation using microchannel having patterned posts
WO2006078470A2 (en) 2005-01-18 2006-07-27 Biocept, Inc. Cell separation using microchannel having patterned posts
US20060199202A1 (en) * 2005-02-09 2006-09-07 Third Wave Technologies, Inc. Detection of allelic expression imbalance
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
US10081839B2 (en) 2005-07-29 2018-09-25 Natera, Inc System and method for cleaning noisy genetic data and determining chromosome copy number
US20070059680A1 (en) * 2005-09-15 2007-03-15 Ravi Kapur System for cell enrichment
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US8921102B2 (en) * 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US10083273B2 (en) 2005-07-29 2018-09-25 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US20070059774A1 (en) * 2005-09-15 2007-03-15 Michael Grisham Kits for Prenatal Testing
US20070059716A1 (en) * 2005-09-15 2007-03-15 Ulysses Balis Methods for detecting fetal abnormality
US20070059719A1 (en) * 2005-09-15 2007-03-15 Michael Grisham Business methods for prenatal Diagnosis
US20100035246A1 (en) * 2005-10-21 2010-02-11 Avner Lushi Methods and Kits for Analyzing Genetic Material of a Fetus
EP3591068A1 (en) * 2006-02-02 2020-01-08 The Board of Trustees of the Leland Stanford Junior University Non-invasive fetal genetic screening by digital analysis
US20070243549A1 (en) * 2006-04-12 2007-10-18 Biocept, Inc. Enrichment of circulating fetal dna
US8372584B2 (en) 2006-06-14 2013-02-12 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
WO2008111990A1 (en) * 2006-06-14 2008-09-18 Cellpoint Diagnostics, Inc. Rare cell analysis using sample splitting and dna tags
EP2076172A4 (en) * 2006-10-27 2012-03-21 Aretais Inc USE OF COHERENT RAMAN PROCEDURES FOR MEDICAL DIAGNOSTIC AND THERAPEUTIC PURPOSES AND CALIBRATION METHOD THEREFOR
US9222936B2 (en) * 2007-04-18 2015-12-29 Solulink, Inc. Methods and/or use of oligonucleotide conjugates for suppressing background due to cross-hybridization
US20090029377A1 (en) 2007-07-23 2009-01-29 The Chinese University Of Hong Kong Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing
US20100112590A1 (en) 2007-07-23 2010-05-06 The Chinese University Of Hong Kong Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing With Enrichment
KR20100061539A (ko) * 2007-09-21 2010-06-07 바이오셉트 인코포레이티드 태아 세포 및 핵산의 동정 및 단리
CA2731991C (en) 2008-08-04 2021-06-08 Gene Security Network, Inc. Methods for allele calling and ploidy calling
US20100240054A1 (en) * 2008-09-22 2010-09-23 Biocept, Inc. Identification and isolation of fetal cells and nucleic acid
EP2857527B1 (en) * 2009-01-07 2018-11-14 Arcedi Biotech ApS Enrichment and identification of fetal cells in maternal blood and ligands for such use
US20120100538A1 (en) 2009-03-24 2012-04-26 Biocept, Inc. Devices and methods of cell capture and analysis
JP5923035B2 (ja) 2009-03-24 2016-05-24 バイオセプト インコーポレイティッド 細胞の捕捉および解析のデバイスおよび方法
SG175282A1 (en) 2009-04-21 2011-11-28 Genetic Technologies Ltd Methods for obtaining fetal genetic material
WO2010150259A1 (en) * 2009-06-24 2010-12-29 Fund For Medical Research Development Of Infrastructure And Health Services -Rambam Medical Center Methods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders
ES2640776T3 (es) 2009-09-30 2017-11-06 Natera, Inc. Métodos para denominar de forma no invasiva ploidía prenatal
US8187979B2 (en) * 2009-12-23 2012-05-29 Varian Semiconductor Equipment Associates, Inc. Workpiece patterning with plasma sheath modulation
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
AU2011255641A1 (en) 2010-05-18 2012-12-06 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
ES2770342T3 (es) 2010-12-22 2020-07-01 Natera Inc Procedimientos para pruebas prenatales no invasivas de paternidad
CN103459613A (zh) * 2011-01-31 2013-12-18 艾索特里克斯遗传实验室有限责任公司 使用结合分子富集微粒或核酸的方法
CA2824387C (en) 2011-02-09 2019-09-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
CN104145027A (zh) * 2011-12-12 2014-11-12 塞雷公司 用于室温原位检测生物样品中的目标核酸的方法和试剂盒
AU2013331171B2 (en) * 2012-10-19 2019-05-30 Wayne State University Identification and analysis of fetal trophoblast cells in cervical mucus for prenatal diagnosis
WO2014201138A1 (en) * 2013-06-11 2014-12-18 Stelling James R Method for detection of fetal abnormalities
US10577655B2 (en) 2013-09-27 2020-03-03 Natera, Inc. Cell free DNA diagnostic testing standards
US9499870B2 (en) 2013-09-27 2016-11-22 Natera, Inc. Cell free DNA diagnostic testing standards
US10262755B2 (en) 2014-04-21 2019-04-16 Natera, Inc. Detecting cancer mutations and aneuploidy in chromosomal segments
RU2717641C2 (ru) 2014-04-21 2020-03-24 Натера, Инк. Обнаружение мутаций и плоидности в хромосомных сегментах
US10330680B2 (en) 2014-10-10 2019-06-25 Wayne State University Methods of assaying RNA from fetal extravillous trophoblast cells isolated from a maternal endocervical sample
US10364467B2 (en) 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
CN105039505A (zh) * 2015-04-14 2015-11-11 广州安必平医药科技股份有限公司 一种用于检测xy染色体异常的fish探针、试剂盒及其制备方法
WO2016183106A1 (en) 2015-05-11 2016-11-17 Natera, Inc. Methods and compositions for determining ploidy
EP3440209A4 (en) 2016-04-06 2019-11-27 Wayne State University ISOLATION AND ANALYSIS OF FETAL DNA FROM EXTRAVILLE THROPHOBLAST CELLS RECOVERED FROM THE ENDOZERVICAL CHANNEL
US11485996B2 (en) 2016-10-04 2022-11-01 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
US20190247030A1 (en) * 2018-02-13 2019-08-15 Trophodiagnostics, Llc System and Method for Collecting, Enriching and Isolating Trophoblast Cells From Endocervical Canal
EP3585889A1 (en) 2017-02-21 2020-01-01 Natera, Inc. Compositions, methods, and kits for isolating nucleic acids
US11525159B2 (en) 2018-07-03 2022-12-13 Natera, Inc. Methods for detection of donor-derived cell-free DNA
CN109055497A (zh) * 2018-08-15 2018-12-21 浙江海洋大学 曼氏无针乌贼胚胎整体原位杂交的方法
TWI668423B (zh) * 2018-10-02 2019-08-11 吳宏偉 細胞分選方法及系統
CN111122857A (zh) * 2018-10-31 2020-05-08 苏州浚惠生物科技有限公司 胎儿滋养层细胞的标志物、鉴定方法、检测试剂盒和应用
CN114041053A (zh) 2019-06-07 2022-02-11 阿塞迪生物技术有限公司 使用facs分离胎儿细胞
WO2022201881A1 (ja) * 2021-03-25 2022-09-29 日本電気株式会社 スライド数推定装置、制御方法、及び非一時的なコンピュータ可読媒体
CN112980779B (zh) 2021-05-20 2021-08-24 广州凯普医药科技有限公司 一种从孕妇宫颈脱落细胞中分离胎盘滋养层细胞的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2935741B2 (ja) * 1988-12-06 1999-08-16 フリンダーズ・テクノロジーズ・プラプライアテリー・リミテッド 出生前診断を可能にする母体血液からの胎児細胞の分離
US5817462A (en) * 1995-02-21 1998-10-06 Applied Spectral Imaging Method for simultaneous detection of multiple fluorophores for in situ hybridization and multicolor chromosome painting and banding
US5991028A (en) * 1991-02-22 1999-11-23 Applied Spectral Imaging Ltd. Spectral bio-imaging methods for cell classification
JPH07505777A (ja) * 1992-04-09 1995-06-29 アイジー・ラボラトリーズ，インコーポレイテッド 一般的な生産の染色体異数体の検出用プローブ
US5750339A (en) * 1994-11-30 1998-05-12 Thomas Jefferson University Methods for identifying fetal cells
JP3127244B2 (ja) * 1999-04-28 2001-01-22 鹿児島大学長 化学発光ｉｎ ｓｉｔｕハイブリダイゼーションと免疫組織化学的染色とを組合わせた二重標識検出法
WO2001033190A2 (en) * 1999-11-04 2001-05-10 Arcturus Engineering, Inc. Automated laser capture microdissection
US20020045196A1 (en) * 2000-05-12 2002-04-18 Walt Mahoney Methods of isolating trophoblast cells from maternal blood
CA2428757A1 (en) * 2000-11-15 2002-07-18 Roche Diagnostics Corporation Methods and reagents for identifying rare fetal cells in the maternal circulation

Also Published As

Publication number Publication date
US20040197832A1 (en) 2004-10-07
JP2006523100A (ja) 2006-10-12
EP1608781A2 (en) 2005-12-28
AU2004225660A1 (en) 2004-10-14
CN1798853A (zh) 2006-07-05
WO2004087863A2 (en) 2004-10-14
KR20050123139A (ko) 2005-12-29
EP1608781A4 (en) 2006-06-21
WO2004087863A3 (en) 2004-12-02
CA2521032A1 (en) 2004-10-14
US20050003351A1 (en) 2005-01-06
ZA200507910B (en) 2007-03-28

Similar Documents

Publication Publication Date Title
MXPA05010532A (es) Diagnostico genetico prenatal no invasivo usando celulas transcervicales.
TW200643175A (en) Markers for prenatal diagnosis and monitoring
WO2007028155A3 (en) Fragment size distribution pattern of amniotic fluid cell-free fetal dna for prenatal diagnosis
WO2008081451A3 (en) Methods and kits for analyzing genetic material of a fetus
TW200700558A (en) A method for the detection of chromosomal aneuploidies
WO2009009769A3 (en) Diagnosis of fetal abnormalities using nucleated red blood cells
WO2006034427A3 (en) Diagnosis of fetal aneuploidy
HK1083227A1 (en) Circulating mrna as diagnostic markers for pregnancy-related disorders
IN2012DN03139A (es)
AU2003263660A1 (en) Prenatal diagnosis of down syndrome by detection of fetal rna markers in maternal blood
HRP20150251T1 (en) Kit for predicting implantation success in assisted fertilisation
WO2005037059A3 (en) Multi-marker screening protocol for fetal abnormalities
WO2007046108A3 (en) Methods and kits for analyzing genetic material of a fetus
WO2004072822A3 (en) Quantitative fetal heart rate and cardiotocographic monitoring system and related method thereof
WO2007106838A3 (en) A non-invasive method for diagnosing fetal cells and cancer cells
Zanella et al. Biochemical profile of amniotic and allantoic fluid during different gestational phases in mares
CA2467904A1 (en) Compositions and methods for accurate early pregnancy diagnosis
Gadelha et al. Amniotic fluid volumetry by three-dimensional ultrasonography during the first trimester of pregnancy
Boehm et al. Chorionic villus sampling: Quality control-A continuous improvement model
Tezuka et al. Comparison of the accuracy of gestational age estimation from fetal heart rate and crown-rump length
Baviera et al. ICAM-1 in maternal serum and amniotic fluid as an early marker of preeclampsia and IUGR
Evans et al. 357: Skewed to the left: under-measurement of NT's and implications for screening efficiency
Fryns et al. Tetraploidy with hydrops fetalis, cystic nuchal hygroma and 90, XX karyotype
Ma et al. Interleukin-1 beta induced lewis X alteration in unexplained recurrent miscarriage
Pilalis et al. COMPARISON OF INCREASED UTERINE ARTERY PULSATILITY INDEX AND BILATERAL NOTCHES AT THE SECOND TRIMESTER IN SCREENING FOR PREECLAMPSIA AND FETAL GROWTH

Legal Events

Date Code Title Description
FA Abandonment or withdrawal